JPET Assistant Professor of Medicine (Clinician-Educator)

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on July 29, 2008; DOI: 10.1124/jpet.108.141788


0022-3565/08/3272-365-374$20.00
JPET 327:365-374, 2008
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.108.141788v1
327/2/365    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Thomas, R. L.
Right arrow Articles by Challiss, R. A. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Thomas, R. L.
Right arrow Articles by Challiss, R. A. J.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*METHYLSCOPOLAMINE NITRATE

CELLULAR AND MOLECULAR

G Protein Coupling and Signaling Pathway Activation by M1 Muscarinic Acetylcholine Receptor Orthosteric and Allosteric Agonists

Rachel L. Thomas, Rajendra Mistry, Christopher J. Langmead, Martyn D. Wood, and R. A. John Challiss

Department of Cell Physiology and Pharmacology, University of Leicester, Leicester, United Kingdom (R.L.T., R.M., R.A.J.C.); and Psychiatry Centre of Excellence in Drug Discovery, GlaxoSmithKline, Harlow, United Kingdom (C.J.L., M.D.W.)

The M1 muscarinic acetylcholine (mACh) receptor is among a growing number of G protein-coupled receptors that are able to activate multiple signaling cascades. AC-42 (4-n-butyl-1-[4-(2-methylphenyl)-4-oxo-1-butyl] piperidine) is an allosteric agonist that can selectively activate the M1 mACh receptor in the absence of an orthosteric ligand. Allosteric agonists have the potential to stabilize unique receptor conformations, which may in turn cause differential activation of signal transduction pathways. In the present study, we have investigated the signaling pathways activated by AC-42, its analog 77-LH-28-1 (1-[3-(4-butyl-1-piperidinyl)propyl]-3,4-dihydro-2(1H)-quinolinone), and a range of orthosteric muscarinic agonists [oxotremorine-M (oxo-M), arecoline, and pilocarpine] in Chinese hamster ovary cells recombinantly expressing the human M1 mACh receptor. Each agonist was able to activate G{alpha}q/11-dependent signaling, as demonstrated by an increase in guanosine 5'-O-(3-thiotriphosphate) ([35S]GTP{gamma}S) binding to G{alpha}q/11 proteins and total [3H]inositol phosphate accumulation assays in intact cells. All three orthosteric agonists caused significant enhancements in [35S]GTP{gamma}S binding to G{alpha}i1/2 subunits over basal; however, neither allosteric ligand produced a significant response. In contrast, both orthosteric and allosteric agonists are able to couple to the G{alpha}s/cAMP pathway, enhancing forskolin-stimulated cAMP accumulation. These data provide support for the concept that allosteric and orthosteric mACh receptor agonists both stabilize receptor conformations associated with G{alpha}q/11- and G{alpha}s-dependent signaling; however, AC-42 and 77-LH-28-1, unlike oxo-M, arecoline, and pilocarpine, do not seem to promote M1 mACh receptor-G{alpha}i1/2 coupling, suggesting that allosteric agonists have the potential to activate distinct subsets of downstream effectors.


Received June 3, 2008; accepted July 28, 2008.

Address correspondence to: Dr. R.A. John Challiss, Department of Cell Physiology and Pharmacology, University of Leicester, Room 4/04, Henry Wellcome Building, Lancaster Road, Leicester LE1 9HN, UK. E-mail: jc36{at}leicester.ac.uk







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2008 by the American Society for Pharmacology and Experimental Therapeutics.